Bone and Parathyroid Strategies for Primary Care-Parathyroid Disease: A 2022 Update

Video Transcription

Video Summary

The first summary is about a Parathyroid Symposium where Dr. Jad Sfeir moderates and presents on behalf of Dr. Alia Khan, who is unable to attend in person. The talk primarily focuses on the updated guidelines for managing primary hyperparathyroidism. Dr. Sfeir discusses the diagnosis criteria, imaging techniques for localizing parathyroid adenomas, and the different clinical phenotypes of the disease. The learning objectives of Dr. Khan's talk are understanding the diagnosis, complications, and management of primary hyperparathyroidism, as well as the new guidelines for management.<br /><br />After Dr. Sfeir's presentation, Dr. Rob Wormers takes the stage to discuss the management of persistent and recurrent hyperparathyroidism. He emphasizes the importance of an experienced surgeon and the use of imaging techniques for localization. He also discusses intraoperative parathyroid hormone measurement as a guide for surgical decisions and non-surgical management options including medications like cinacalcet and the role of genetic testing in certain cases.<br /><br />The second summary is about a presentation on hypoparathyroidism. The presenter discusses the diagnosis and management of the condition, which is characterized by low levels of serum calcium and parathyroid hormone. Treatment involves maintaining low normal levels of serum calcium and high normal levels of serum phosphorus through the use of calcium supplements and calcitriol. The presenter highlights the challenges in managing hypoparathyroidism and mentions that new medications are being developed. They also discuss the epidemiology of the condition and potential increased mortality in some patients. The presentation concludes by summarizing the current management guidelines for hypoparathyroidism.

Keywords

Parathyroid Symposium

primary hyperparathyroidism

diagnosis criteria

imaging techniques

clinical phenotypes

management guidelines

persistent hyperparathyroidism

experienced surgeon

intraoperative parathyroid hormone measurement

hypoparathyroidism

calcium supplements